Maediastinal germ cell tumors: analysis using hospital-based cancer registry data in Japan.

IF 2.4 3区 医学 Q3 ONCOLOGY
Reo Takahashi, Satoshi Nitta, Shuya Kandori, Shuhei Suzuki, Kazuki Hamada, Kozaburo Tanuma, Kosuke Kojo, Masanobu Shiga, Shotaro Sakka, Yoshiyuki Nagumo, Bryan J Mathis, Akio Hoshi, Hiromitsu Negoro, Ayako Okuyama, Takahiro Higashi, Hiroyuki Nishiyama
{"title":"Maediastinal germ cell tumors: analysis using hospital-based cancer registry data in Japan.","authors":"Reo Takahashi, Satoshi Nitta, Shuya Kandori, Shuhei Suzuki, Kazuki Hamada, Kozaburo Tanuma, Kosuke Kojo, Masanobu Shiga, Shotaro Sakka, Yoshiyuki Nagumo, Bryan J Mathis, Akio Hoshi, Hiromitsu Negoro, Ayako Okuyama, Takahiro Higashi, Hiroyuki Nishiyama","doi":"10.1007/s10147-024-02607-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Mediastinal germ cell tumors are rare and few large-scale studies on mediastinal germ cell tumors are reported. We aimed to investigate the clinical characteristics and survival outcomes of patients with mediastinum germ cell tumors in Japan.</p><p><strong>Methods: </strong>A hospital-based cancer registry data in Japan was used to identify and enroll patients diagnosed with mediastinal germ cell tumors in 2012-2013. The datasets were registered from 80 institutions.</p><p><strong>Results: </strong>The selection criteria were met by 123 patients, the majority of whom were male. The median age at diagnosis was 39 years (range 25-89 years) and the most common age groups at diagnosis was 30-39 years, followed by 40-49 years and ≥ 50 years. The histology of non-seminoma (55.3%) was slightly more frequent than that of seminoma (44.7%). The most common histological subtype in non-seminoma was yolk sac tumor, followed by mixed germ cell tumor. The 5-year survival of seminoma and non-seminoma were 96.4% and 57.3%, respectively (p < 0.001). Non-seminomatous mediastinal germ cell tumors, malignant teratomas, mixed germ cell tumors, and yolk sac tumors had comparable survival rates, while those with choriocarcinoma showed the worst prognosis.</p><p><strong>Conclusions: </strong>This is the first report showing the clinical characteristics and survival outcomes of mediastinal germ cell tumors in Japan using a real-world large cohort database.</p>","PeriodicalId":13869,"journal":{"name":"International Journal of Clinical Oncology","volume":" ","pages":"1756-1761"},"PeriodicalIF":2.4000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Clinical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10147-024-02607-y","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/5 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Mediastinal germ cell tumors are rare and few large-scale studies on mediastinal germ cell tumors are reported. We aimed to investigate the clinical characteristics and survival outcomes of patients with mediastinum germ cell tumors in Japan.

Methods: A hospital-based cancer registry data in Japan was used to identify and enroll patients diagnosed with mediastinal germ cell tumors in 2012-2013. The datasets were registered from 80 institutions.

Results: The selection criteria were met by 123 patients, the majority of whom were male. The median age at diagnosis was 39 years (range 25-89 years) and the most common age groups at diagnosis was 30-39 years, followed by 40-49 years and ≥ 50 years. The histology of non-seminoma (55.3%) was slightly more frequent than that of seminoma (44.7%). The most common histological subtype in non-seminoma was yolk sac tumor, followed by mixed germ cell tumor. The 5-year survival of seminoma and non-seminoma were 96.4% and 57.3%, respectively (p < 0.001). Non-seminomatous mediastinal germ cell tumors, malignant teratomas, mixed germ cell tumors, and yolk sac tumors had comparable survival rates, while those with choriocarcinoma showed the worst prognosis.

Conclusions: This is the first report showing the clinical characteristics and survival outcomes of mediastinal germ cell tumors in Japan using a real-world large cohort database.

Abstract Image

前庭生殖细胞瘤:利用日本医院癌症登记数据进行分析。
目的:纵隔生殖细胞瘤非常罕见,有关纵隔生殖细胞瘤的大规模研究报道很少。我们旨在调查日本纵隔生殖细胞瘤患者的临床特征和生存结果:方法:利用日本医院的癌症登记数据,对2012-2013年确诊为纵隔生殖细胞瘤的患者进行识别和登记。结果:符合入选标准的患者有123例:123名患者符合选择标准,其中大部分为男性。确诊时的中位年龄为39岁(范围为25-89岁),最常见的年龄组为30-39岁,其次为40-49岁和≥50岁。非精原细胞瘤组织学类型(55.3%)略高于精原细胞瘤组织学类型(44.7%)。非精原细胞瘤中最常见的组织学亚型是卵黄囊肿瘤,其次是混合性生殖细胞瘤。精原细胞瘤和非精原细胞瘤的 5 年生存率分别为 96.4% 和 57.3%(P 结论:精原细胞瘤和非精原细胞瘤的 5 年生存率分别为 96.4% 和 57.3%:这是第一份利用真实世界大型队列数据库显示日本纵隔生殖细胞瘤临床特征和生存结果的报告。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.80
自引率
3.00%
发文量
175
审稿时长
2 months
期刊介绍: The International Journal of Clinical Oncology (IJCO) welcomes original research papers on all aspects of clinical oncology that report the results of novel and timely investigations. Reports on clinical trials are encouraged. Experimental studies will also be accepted if they have obvious relevance to clinical oncology. Membership in the Japan Society of Clinical Oncology is not a prerequisite for submission to the journal. Papers are received on the understanding that: their contents have not been published in whole or in part elsewhere; that they are subject to peer review by at least two referees and the Editors, and to editorial revision of the language and contents; and that the Editors are responsible for their acceptance, rejection, and order of publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信